Genetic News and Research

RSS

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it is advancing its Development Candidate for ALN-AS1, an RNAi therapeutic targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of hepatic porphyrias including acute intermittent porphyria (AIP).

9 Oct 2013

Forma Achieves First Milestone In Celgene Collaboration

...

8 Oct 2013

J&J's Janssen Buys Rights To Hepatitis C Compound From GSK

...

8 Oct 2013

Clinical Genomics Nabs Enterix, Aims To Launch New Bowel Cancer Blood Test

...

8 Oct 2013

Researchers who contributed to field of medicine receive Keio Medical Science Prize

The 18th Keio Medical Science Prize has been awarded to Victor R. Ambros, PhD, professor of molecular medicine at the University of Massachusetts Medical School and the Silverman Chair in Natural Science; and Shigekazu Nagata, PhD, professor of medical chemistry in the Graduate School of Medicine at Kyoto University.

8 Oct 2013

Scientists to highlight Bio-Rad's Droplet Digital PCR applications at CHI Digital PCR Conference

Since its introduction in 2011, Bio-Rad Laboratory's Droplet Digital PCR (ddPCR-) technology has demonstrated the potential to be a transformative technology, particularly in clinical applications.

8 Oct 2013

Researchers re-invented class of popular antimicrobial drugs by altering their chemical structures

By tinkering with their chemical structures, researchers at the University of California, San Diego School of Medicine have essentially re-invented a class of popular antimicrobial drugs, restoring and in some cases, expanding or improving, their effectiveness against drug-resistant pathogens in animal models.

8 Oct 2013

Professor receives $1.3M EUREKA grant to explore communication between cytoplasm and nucleus

University of Massachusetts Medical School Professor and Vice Chair of Neurobiology Vivian Budnik, PhD, has received a four-year, $1.3 million EUREKA (Exceptional Unconventional Research Enabling Knowledge Acceleration) grant from the National Institute of Neurological Disorders and Stroke to explore a novel mechanism of communication between the cytoplasm and the nucleus, called nuclear envelope budding, that may lead to new understandings for various tissue dystrophies and aging disorders.

8 Oct 2013

Gene involved in regulation of serotonin predicts how much our emotions affect our relationships

What makes some people more prone to wedded bliss or sorrow than others? Researchers at UC Berkeley and Northwestern University have found a major clue in our DNA. A gene involved in the regulation of serotonin can predict how much our emotions affect our relationships, according to a new study that may be the first to link genetics, emotions, and marital satisfaction. The study was conducted at UC Berkeley.

8 Oct 2013

Parasites in patients who relapse after leishmaniasis treatment may have greater infectivity

Relapses after treatment for Leishmania infection may be due to a greater infectivity of the parasite rather than drug resistance, as has been previously thought, according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.

8 Oct 2013

PMDD may shed light on complex interactions between sex hormones and mood

Improved understanding of the role of female sex hormones on the drivers and symptoms of premenstrual dysphoric disorder (PMDD) may shed light on the complex interactions between sex hormones and mood, potentially helping to explain the increased prevalence of mood disorders in women.

8 Oct 2013

New research identifies protein that controls formation of different types of mature blood cells

New research in the Journal of Experimental Medicine identifies a protein that controls the formation of different types of mature blood cells - a finding that could be important to developing new treatments for blood diseases and helping realize the potential of regenerative medicine.

8 Oct 2013

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

Eddingpharm continued to aggressively build its product portfolio by inking another cancer agreement, this time with Immutep. In this latest agreement, Eddingpharm was granted exclusive rights to develop and market ImmuFact® IMP321 in mainland China, Hong Kong, Macau, and Taiwan.

7 Oct 2013

A*STAR, Debiopharm Team Up To Develop Epigenetic Cancer Target

...

7 Oct 2013

GSK Adds Another Program To Isis Antisense Collab

...

7 Oct 2013

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.

7 Oct 2013

Brain & Behavior Research Foundation to honor 7 scientists for exceptional research on mental health

The Brain & Behavior Research Foundation celebrates the transformative power of neuroscience and psychiatric research to improve the lives of those with mental illness. Seven exceptional scientists will be honored at the Annual National Awards Dinner at the Pierre Hotel in New York City on Friday, October 25, 2013.

7 Oct 2013

Study shows how evolution shaped lungs through successive optimizations of physical parameters

Two French physicists, Bernard Sapoval and Marcel Filoche from -cole Polytechnique in Palaiseau, France, suggest in a study published in EPJ E how evolution has shaped our lungs through successive optimisations of physical parameters such as conservation of energy and speed of delivery.

7 Oct 2013

Scientists at Oklahoma Medical Research Foundation identify six new Sj-gren-related genes

With the completion of the first genome-wide association study for Sj-gren's syndrome, an international coalition of researchers led by scientists at the Oklahoma Medical Research Foundation has identified six new disease-related genes.

7 Oct 2013

ERK pathway discovery may provide therapeutic options for treating drug addictions

The extracellular-signal regulated kinase (ERK) pathway plays a role in multiple drug addictions and appears to modulate neuronal plasticity through epigenetic mechanisms, say French scientists.

7 Oct 2013

Genetic News and Research

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Forma Achieves First Milestone In Celgene Collaboration

J&J's Janssen Buys Rights To Hepatitis C Compound From GSK

Clinical Genomics Nabs Enterix, Aims To Launch New Bowel Cancer Blood Test

Researchers who contributed to field of medicine receive Keio Medical Science Prize

Scientists to highlight Bio-Rad's Droplet Digital PCR applications at CHI Digital PCR Conference

Researchers re-invented class of popular antimicrobial drugs by altering their chemical structures

Professor receives $1.3M EUREKA grant to explore communication between cytoplasm and nucleus

Gene involved in regulation of serotonin predicts how much our emotions affect our relationships

Parasites in patients who relapse after leishmaniasis treatment may have greater infectivity

PMDD may shed light on complex interactions between sex hormones and mood

New research identifies protein that controls formation of different types of mature blood cells

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

A*STAR, Debiopharm Team Up To Develop Epigenetic Cancer Target

GSK Adds Another Program To Isis Antisense Collab

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Brain & Behavior Research Foundation to honor 7 scientists for exceptional research on mental health

Study shows how evolution shaped lungs through successive optimizations of physical parameters

Scientists at Oklahoma Medical Research Foundation identify six new Sj-gren-related genes

ERK pathway discovery may provide therapeutic options for treating drug addictions

Sequencing & Genomics: Elevating Science and Healthcare eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News